Archives

Why Facebook Just a Bought a Brain Control Startup: Term Sheet

Sep 24, 2019 | Limited Partner Relationships, Lux Capital

This was one of their crazier portfolio companies. Though I am glad to read the news I am sad to miss the LP updates on this one. As Fortune mentions: Well, it looks like CTRL-labs won’t be raising another round after all. Facebook has swooped in and agreed to acquire...

Tocagen fails brain cancer test, sets about ‘operational review’ as shares routed

Sep 12, 2019 | Tocagen

In the long game you cannot expect all news to be good. As FierceBiotech writes: It was always going to be a long shot, given how tough brain cancer is to treat and the litany of failures left tin its wake, but Tocagen, perhaps inevitably, has seen its attempt flop,...

Poop-testing startup uBiome was once valued at $600 million by Silicon Valley’s top VCs. It just filed for bankruptcy.

Sep 4, 2019 | Syndicates, uBiome

When the poop hits the fan… As Business Insider writes: Silicon Valley gut-health startup uBiome has filed for bankruptcy protection, capping months of challenges and setbacks for the once-buzzy startup. Read the full Article

Why Facebook Just a Bought a Brain Control Startup: Term Sheet

Tocagen fails brain cancer test, sets about ‘operational review’ as shares routed

Poop-testing startup uBiome was once valued at $600 million by Silicon Valley’s top VCs. It just filed for bankruptcy.

Recent Posts

Categories